Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peimeng You

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Seminars in Cancer Biology|March 3, 2023
Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancerJunyu Li, Lin Li, Peimeng You, et al.
BMC Cancer|October 31, 2024
PD-1/PD-L1 immune checkpoint inhibitors in the treatment of unresectable locally advanced or metastatic triple negative breast cancer: a meta-analysis on their efficacy and safetyZuxiu Wang, Peimeng You, Zhanglei Yang, et al.
Experimental Hematology & Oncology|August 5, 2024
Overexpression of ESYT3 improves radioimmune responses through activating cGAS-STING pathway in lung adenocarcinomaZan Luo, Ying Li, Bin Xu, et al.
Respiratory Research|April 11, 2025
Prediction of radiosensitivity in non-small cell lung cancer based on computed tomography and tumor genomics: a multiple real world cohort studyPeimeng You, Qiaxuan Li, Yu Lei, et al.
Journal of Cancer Research and Clinical Oncology|September 1, 2023
Radiation-sensitive genetic prognostic model identifies individuals at risk for radiation resistance in head and neck squamous cell carcinomaPeimeng You, Shengbo Liu, Qiaxuan Li, et al.
Frontiers in Immunology|July 6, 2026
Single dose of 5 Gy can damage erythrocytes and consequently induces lymphocyte depletion in spleen and circulating bloodPeimeng You, Xiaohang Qin, Yinghui Li, et al.
Frontiers in Immunology|September 30, 2022
Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinomaQiaxuan Li, Daipeng Xie, Lintong Yao, et al.
Journal for Immunotherapy of Cancer|October 21, 2023
Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB-IV NSCLC (LCDigital-IO Study): a multicenter retrospective studyShaowei Wu, Weijie Zhan, Lan Liu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Seminars in Cancer Biology|March 3, 2023
Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancerJunyu Li, Lin Li, Peimeng You, et al.
BMC Cancer|October 31, 2024
PD-1/PD-L1 immune checkpoint inhibitors in the treatment of unresectable locally advanced or metastatic triple negative breast cancer: a meta-analysis on their efficacy and safetyZuxiu Wang, Peimeng You, Zhanglei Yang, et al.
Experimental Hematology & Oncology|August 5, 2024
Overexpression of ESYT3 improves radioimmune responses through activating cGAS-STING pathway in lung adenocarcinomaZan Luo, Ying Li, Bin Xu, et al.
Respiratory Research|April 11, 2025
Prediction of radiosensitivity in non-small cell lung cancer based on computed tomography and tumor genomics: a multiple real world cohort studyPeimeng You, Qiaxuan Li, Yu Lei, et al.
Journal of Cancer Research and Clinical Oncology|September 1, 2023
Radiation-sensitive genetic prognostic model identifies individuals at risk for radiation resistance in head and neck squamous cell carcinomaPeimeng You, Shengbo Liu, Qiaxuan Li, et al.
Frontiers in Immunology|July 6, 2026
Single dose of 5 Gy can damage erythrocytes and consequently induces lymphocyte depletion in spleen and circulating bloodPeimeng You, Xiaohang Qin, Yinghui Li, et al.
Frontiers in Immunology|September 30, 2022
Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinomaQiaxuan Li, Daipeng Xie, Lintong Yao, et al.
Journal for Immunotherapy of Cancer|October 21, 2023
Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB-IV NSCLC (LCDigital-IO Study): a multicenter retrospective studyShaowei Wu, Weijie Zhan, Lan Liu, et al.
Pageof 1